- Home
- TFINP vs RVPHW Comparison
TFINP vs RVPHW Comparison
Compare TFINP & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFINP
- RVPHW
- Stock Information
- Founded
- TFINP N/A
- RVPHW 2018
- Country
- TFINP United States
- RVPHW United States
- Employees
- TFINP 1576
- RVPHW 14
- Industry
- TFINP Major Banks
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- TFINP Finance
- RVPHW Health Care
- Exchange
- TFINP Nasdaq
- RVPHW Nasdaq
- Market Cap
- TFINP N/A
- RVPHW N/A
- IPO Year
- TFINP N/A
- RVPHW N/A
- Fundamental
- Price
- TFINP $22.42
- RVPHW $0.03
- Analyst Decision
- TFINP
- RVPHW
- Analyst Count
- TFINP 0
- RVPHW 0
- Target Price
- TFINP N/A
- RVPHW N/A
- AVG Volume (30 Days)
- TFINP N/A
- RVPHW 22.4K
- Earning Date
- TFINP N/A
- RVPHW 03-14-2025
- Dividend Yield
- TFINP N/A
- RVPHW N/A
- EPS Growth
- TFINP N/A
- RVPHW N/A
- EPS
- TFINP N/A
- RVPHW N/A
- Revenue
- TFINP N/A
- RVPHW N/A
- Revenue This Year
- TFINP N/A
- RVPHW N/A
- Revenue Next Year
- TFINP N/A
- RVPHW N/A
- P/E Ratio
- TFINP N/A
- RVPHW N/A
- Revenue Growth
- TFINP N/A
- RVPHW N/A
- 52 Week Low
- TFINP N/A
- RVPHW $0.13
- 52 Week High
- TFINP N/A
- RVPHW $0.15
- Technical
- Relative Strength Index (RSI)
- TFINP 54.91
- RVPHW N/A
- Support Level
- TFINP $22.09
- RVPHW N/A
- Resistance Level
- TFINP $22.43
- RVPHW N/A
- Average True Range (ATR)
- TFINP 0.11
- RVPHW 0.00
- MACD
- TFINP -0.00
- RVPHW 0.00
- Stochastic Oscillator
- TFINP 54.41
- RVPHW 0.00
About TFINP Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.